Desmoplastic Mesothelioma

Desmoplastic mesothelioma is a rare and aggressive subtype of sarcomatoid mesothelioma in which more than half of the tumor is made up of dense, scar-like fibrous tissue containing relatively few cancer cells. Because it looks so much like ordinary scarring, it is one of the most difficult mesotheliomas to diagnose and typically carries the worst prognosis of all mesothelioma subtypes.

Origin

The term combines the Greek desmos (band or bond) and plassein (to form), referring to the dense fibrous bands that define the tumor. Desmoplastic mesothelioma was formally characterized as a distinct pattern in the late 1970s and early 1980s, notably in pathology work by Kannerstein and Churg, and is now recognized by the World Health Organization as a variant of sarcomatoid mesothelioma.

Significance in Asbestos Context

For patients, desmoplastic mesothelioma matters in two big ways. First, it is easy to miss or misread on biopsy. The dense scar tissue can look like benign pleural fibrosis, healed pleurisy, or post-surgical scarring, so a confident diagnosis often requires a large tissue sample, expert pathology review, and immunohistochemical stains. Second, it tends to grow and spread quickly and responds poorly to surgery, chemotherapy, and radiation, which affects treatment planning, eligibility for clinical trials, and prognosis discussions with your family. Because the diagnosis is difficult and consequential, asking for a second pathology opinion at a mesothelioma specialty center is especially important with this subtype.

Example Sentence

After the first biopsy was read as benign fibrous pleurisy, a second review at a specialty center identified the lesion as desmoplastic mesothelioma, which changed both her treatment plan and the timeline of her asbestos claim.

Related Terms

Sarcomatoid Mesothelioma, Epithelioid Mesothelioma, Biphasic Mesothelioma, Immunohistochemistry, Pleural Fibrosis, Mesothelioma

Notes

• Ask whether your pathology slides have been reviewed by a mesothelioma-experienced pathologist; misclassification as benign scarring is a known risk with this subtype.
• Request that the pathology report specify the percentage of desmoplastic (dense fibrous) tissue and whether features such as bland necrosis, invasion of fat or skeletal muscle, or sarcomatoid foci are present. These are the criteria used to distinguish it from benign fibrous pleuritis.
• Preserve all imaging (CT, PET, MRI) and the original biopsy blocks; these may be needed for second opinions, clinical trial enrollment, and as evidence in a legal claim.
• Because this subtype is aggressive, ask early about palliative care, clinical trial options, and whether you are a candidate for multimodal therapy at a specialized center.
• Document your full occupational and household asbestos exposure history while you are able; the rarity and severity of this subtype make a complete exposure record especially important for any compensation claim.